.After antibody-drug conjugate (ADC) professional Seagen was offered to Pfizer in 2013 for a tremend...
.On the heels of a phase 3 win that failed to wow capitalists, Ironwood Pharmaceuticals is actually ...
.Do not cease Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizi...
.Accept to recently's Chutes & Ladders, our summary of significant management hirings, shootings ...
.Commemorating his firm's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer called t...
.AbbVie has actually gone back to the source of its antipsychotic giant Vraylar searching for yet an...
.GenSight Biologics is full weeks away from lacking money. Again. The biotech just possesses enough ...
.Monopar Therapeutics is bouncing back a drug from the scrap heap of AstraZeneca's rare illness pipe...
.Along with new records out on Arcus Biosciences' speculative HIF-2a prevention, one team of profess...
.After forming a genetics treatment partnership along with Dyno Therapies in 2020, Roche is back for...